Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial is a research paper published in Translational Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 7 R01 CA207645–03
National Institutes of Health
Grant: 5R01CA207645-02
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
Fields of Study
Keywords
Sustainable Development Goals